We want to hear from you! Reach out to us to through one of the channels below.
#140, 14315 – 118 Avenue
Edmonton, AB T5L 4S6
Canada
Telephone: +1 (250) 744-2487
Fax: +1 (250) 708-4345
77 Upper Rock Circle – Suite 700
Rockville, MD 20850 USA
Business Development: bd@auriniapharma.com
Investor Relations: ir@auriniapharma.com
Clinical Trials: clinicaltrials@auriniapharma.com
Medical Information: medinfo@auriniapharma.com
Corporate Communications and Media Inquiries: achristopher@auriniapharma.com
If you are a healthcare provider and would like to request information on LUPKYNIS®, contact us at Medinfo@auriniapharma.com.
To report a suspected Adverse Event (AE) or Product Quality Complaint, (PQC), select one of the following methods:
AEs can also be reported to the FDA's Adverse Event Reporting System MedWatch Online Voluntary Reporting Form or call 1-800-332-1088.